Table S1 Plasmids and Primers Used in This Study

Recommend Documents

Table S1. Plasmids, strains and primers used in this ...

pNE1 PermAM-FLAG-RitR (C128A). Maule et.al. 2015. pE-SUMO. N-terminal His6-SUMO fusion protein expression vector. Life Sensors Inc. pE-SUMO-RitRWT.

Table S1. Plasmids used and constructed in this study ... - PLOS

Expression vector to generate fusions to the C-terminus of maltose binding protein (MBP). New England Biolabs. pEGFP-c1. Transfection vector. Clontech.

S1 Table. Strains and plasmids used in this study - PLOS

codY-R61A/Îrli60. codY-R61A and rli60 double mutant. This study. WT ilvD-6his. C terminus 6-his tagged ilvD (at the native locus). This study. ÎcodY ilvD-6his.

Table S1. Oligonucleotide primers used in this study ... - PLOS

CGA ATT GTG GAT AAG CTT TCA TCT GC. pG+host4 flanking multiple cloning site. M14. TTG TAA AAC GAC GGC CAG TGA. RedR. ACA GGA AAC AGC TAT ...

S1 Table. Plasmids used in this study - PLOS

10.1128/JB.188.5.1856-1865.2006. PubMed PMID: 16484196; PubMed Central. PMCID: PMC1426569. 2. Chan K, Knaak T, Satkamp L, Humbert O, Falkow S, ...

Table S1: Strains, Plasmids and Primers

pBAD30 plasmid with GFP and mCherry tandem reporter with their respective Shine-Dalgarno sequences. This work. pBAD30mw721. pBAD30mw700 with PPP ...

Table S1. Bacterial strains and plasmids used in this ...

Table S1. Bacterial strains and plasmids used in this study. Strain/plasmid. Descriptiona. Source. S. pneumoniae. D39. Serotype 2 strain, cps 2. PcopY-lacZ.

SUPPLEMENT Table S1. Primers used in protocol

$2,400. $99,776. Oligo Pool amplification with. Kapa HiFi Uracil+. $24. -. USER treatment + End Repair. $36. -. Assembly PCR. $12. -. Sequence Verification.

Supplementary Table S1: Strains and plasmids used

Shuai Zhao Â· Wei-Lan Mo Â· Fan Wu Â· Wei Tang Â· Ji-Liang Tang Â· Boris Szurek Â· ValÃ©rie. 5. VerdierÂ· Ralf Koebnik Â· Jia-Xun Feng. 6. 7. S. Zhao Â· W.-L. Mo Â· F. Wu ...

Table S1. Primers used in the study Experiment Primer ... - PLOS

Q-RT-PCR. Human Hsp70-2 forward. TGTTTGTCTTTGAGGTGGAC. Human Hsp70-2 reverse. AAGAATTCTAATGAACATATCGGT. TG. Human NFAT5 forward.

Table S1 List of primers used in the study

51.25 kDa recombinant OsPAP21b protein (2 Âµg) purified by Ni2+-affinity chromatography. (d) Western blot analysis of purified 6XHIS-OsPAP21b with anti-.

Table S1. Primers Used in Study *Underline denotes ...

GAT CAA ATT TAT GGT TTG ATC GCT ATT CG. Arm 2 of relAÎSYN mutagenesis. RelA::D264G-D. GGC CAC ATA GCC CTG CTC. Arm 2 of relAÎSYN ...

Table S1. Primers used in the study. Name Sequence

Cytokinin (BAP) bud induction assay. WT protonemal tissue (a) and (c);. âdek1 protonemal tissue (b) and (d). Protonemal tissue in (c) and (d) were treated for 48.

Table S1 Primers used in our experiments Primers Primer ... - mBio

Page 1. Primer sequences(5'+ '. Page 2. Page 3. Page 4.

Table S2. Strains, plasmids, and primers used in

ÎpsmÎ±Î²hldÎpmtR. ÎpsmÎ±Î²hld with pmtR gene deleted. This study. Îagr. S. aureus MW2 with agr system deleted. (Wang et al., 2007). E. coli BL21 (DE3).

Supplementary Table S1 Sequences of primers used

5-Methylthioribose 1-phosphate. 1.41E-05. 0.99. 0.05. 1.18. 0.90. 0.38 1.33. 2M+FA-H ... 6.07 606.07 C17H27N3O17P2 UDP-N-acetyl-D-mannosamine. 7.63E-14 ..... 11.27 1.62 29.28 1.86 0.28 1.93 0.14 1.40 1.93 1.21 .... V. 35.68+1 7.14%. â. â. â. 3-

1 Table S2. Plasmids used in this study - PLOS

pPN011. AmpR; pasTI (from CFT073) cloned into BamHI, KpnI of pRR48. This study. pPN012. AmpR; pasT (from CFT073) with C-terminal FLAG cloned into PstI,.

Supporting Table S1. Strains, plasmids and primers. L. pneumophila

1. Supporting Table S1. Strains, plasmids and primers. L. pneumophila strains. Name. Genotype. Reference. Lp01. L.pneumophila serogroup 1, strain Lp01 rpsL.

1 Table S3. Plasmids used in this study. - PLOS

Plasmids for engineered CRISPR arrays. pBAD30. Arabinose inducible expression vector, ApR. [1]. pC1-780. CRISPR1 with 780 bp leader and no spacers, ApR.

S2 Table. Plasmids used in this study - PLOS

Plasmids. Description. Source. pKM190. spoIVFB-yfp (spec) (single crossover integration). This work. pKM261. ycgO::PspoIVF-spoIVFB(E44Q)-yfp (erm).

S3 Table. Plasmids used in this study. Plasmid Description ... - PLOS

S3 Table. Plasmids used in this study. Plasmid. Description. Reference/Source. Bacterial two-hybrid constructs: pBRÎ±. Encodes the full-length Î± subunit of.

Table S2. Plasmids used in this study - PLOS

pDONR 4-1 (PcPEX11B). pDONRTM P4-P1R with 5' flanking region of pex11B; KanR. This study. pDONR 2-3 (PcPEX11B). pDONRTM P2R-P3 with 3' flanking ...

TABLE S2. The PCR primers used in this study ...

ggggaccactttgtacaagaaagctgggtCCATTAATTTACGAGCGATTTCAACT. sdhB-att1. ggggacaagtttgtacaaaaaagcaggctTATTATGGCAACGGGTGGCCC. sdhB-rev1.

Table S5. Primers Used in this Study. Primer Number Sequence

Primer Number. Sequence. Information. CGCGCGCCAAGCTTGATGTCTTTGTTCA Clone LapD for B2H Fwd. AACAGCTGTTGATCGCTATC.

Table S1 Plasmids and Primers Used in This Study

Download PDF

0 downloads 0 Views 82KB Size Report

Comment

Oct 8, 2014 - DONOR VECTOR. USED. pAA11. attL4::wee-1.3 short promoter::attR1. oAKA2 and oAKA3. pDONR(P4-P1r). pAA13. attR2::wee-1.3 3'UTR:: ...

Table S1 Plasmids and Primers Used in This Study PLASMID

DESCRIPTION OF PLASMID INSERT

pAA11 pAA13

attL4::wee-1.3 short promoter::attR1 attR2::wee-1.3 3'UTR::attL3

PRIMERS USED TO GENERATE PLASMID oAKA2 and oAKA3 oAKA6 and oAKA9

DONOR VECTOR USED pDONR(P4-P1r) pDONR(P2r-P3)

pAA15

attR2::wee-1.3 gene + wee-1.3 3'UTR::attL3

oAKA5 and oAKA9

pDONR(P2r-P3)

pAA32

attL4::wee-1.3 short promoter + wee-1.3 gene::attR1

oAKA51 and oAKA52

pDONR(P4-P1r)

pCR110

attL1-GFP with introns (no stop)-attL2

pCR347 pCR319

attL1-mCherry (no stop)-attL2 attR4 - attR3; C.elegans unc-119(+)

pNU162

fib-1 prom::FIB-1::eGFP::fib-1 3’ UTR + unc-119(+)

pDONR P4 P1R

attP4 – attP1R

pDONR P2R P3

attP2R – attP3

PRIMER

PRIMER SEQUENCE (5’  3’)

AMPLIFIES

oAKA2

GGGGACAACTTTGTATAGAAAAGTTGGCcaacatcagaaattcaag

attB4- wee-1.3 promoter (forward)

oAKA3 oAKA5

GGGGACTGCTTTTTTGTACAAACTTGGcattttcactgaaaatg ggggacagctttcttgtacaaagtggTTATGGACGACACAGAGGGTAACTC

attB1- wee-1.3 promoter (reverse) attB2- wee-1.3 gene (forward)

oAKA6

ggggacagctttcttgtacaaagtggGGTAAtaatgcacaaaaatcagaaa

attB2- wee-1.3 3’UTR (forward)

oAKA9 oAKA51

ggggacaactttgtataataaagttgCgtcctacctccagtactacaagaacagg GGGGACAACTTTGTATAGAAAAGTTGGCaccccaaccattgcaaatatgtg

attB3- wee-1.3 3’UTR (reverse) attB4- wee-1.3 promoter (forward)

oAKA52

GGGGACTGCTTTTTTGTACAAACTTGCaacctcgtcgcctgatgatcc

attB1- wee-1.3 gene (reverse)

B4F2

ggggacaactttgtatagaaaagttggcACGTGGATGAATGAGAGCAGC

attB4- cbd-1 promoter (forward)

B1R3

ggggactgcttttttgtacaaacttggATATCCCGATTTATCATCATTGTACG

attB1- cbd-1 gene (reverse)

B2rF2 B3R1

ggggacagctttcttgtacaaagtggccTGATAAGTTGTTCTAAACACCCCC ggggacaactttgtataataaagttggGCGTCCCTTTCACATTTACAG

attB2- cbd-1 3’UTR (forward) attB3- cbd-1 3’UTR (reverse)

oAKA70

ggtggttcctccggaaagaa

act-1 (forward)

oAKA71

gctatgttccagccatccttct

act-1 (reverse)

oAKA88

gaataatgtgatcgacgaggctcc

wee-1.3 (forward)

oAKA89

tcttctacgtggcgattccgattg

wee-1.3 (reverse)

oAKA80 oAKA81

tctcaccatcgttctctctcactg tcggtgggagtgaagaatgg

vet-1 (forward) vet-1 (reverse)

oAKA84

gtgcttaactttccatccgttg

vet-4 (forward)

oAKA85

caacccagtttctctggaagtc

vet-4 (reverse)

oAKA76

ggaagaatgttcaagcggcac

vet-6 (forward)

oAKA77

tccgtctctgatggcttcttctc

vet-6 (reverse)

6 SI

A. K. Allen, J. E. Nesmith, and A. Golden